Thomas M Zollner on OCEANIC-STROKE Study: Amazingly Good News for Patients With Stroke
Thomas M Zollner, Reproductive Health Cluster Lead at Bayer, reposted from Alexander Krupp on LinkedIn:
”Amazingly good news for patients with stroke: The Phase III study OCEANIC-STROKE in secondary stroke prevention met its primary endpoint.
Asundexian 50 mg once daily significantly reduced the risk of ischemic stroke compared to placebo, both in combination with antiplatelet therapy, in patients after a non-cardioembolic ischemic stroke or high-risk ischemic attack.
OCEANIC-STROKE is the first successfully completed Phase III study of a FactorXIa Inhibitor.
Each year, approximately 12 million people worldwide will experience a stroke.
Of these, 20-30% will be a recurrent stroke.
Despite available secondary stroke prevention options, the risk of secondary stroke remains high.
One in five stroke survivors will have another stroke within five years.”
Quoting Alexander Krupp‘s post:
”A new medicine was born today: We are just announcing positive results of the OCEANIC STROKE study in secondary stroke prevention.
There a few moments in a worklife when you can be part of a novel medicine being born.
For me, this is today: We are bringing a novel treatment option to millions of patients to reduce the risk of secondary ischemic stroke.
I am humble and honored to be part of such an incredible TeamBayer that has just made the impossible possible, unlocking superpowers in a new operating model DSO.
Thank you!”
Stay updated with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy